
Business
AstraZeneca to acquire EsoBiotec for up to $1 billion
AstraZeneca will acquire biotechnology firm EsoBiotec for up to $1 billion. EsoBiotec’s “Engineered NanoBody Lentiviral (ENaBL) platform can genetically

AstraZeneca will acquire biotechnology firm EsoBiotec for up to $1 billion. EsoBiotec’s “Engineered NanoBody Lentiviral (ENaBL) platform can genetically